almagate has been researched along with Injuries, Radiation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delle Noci, N; Iaculli, C; Prascina, F; Querques, G | 1 |
Giuliari, GP; Hinkle, DM; Sadaka, A; Simpson, ER | 1 |
1 review(s) available for almagate and Injuries, Radiation
Article | Year |
---|---|
Current treatments for radiation retinopathy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Brachytherapy; Eye Neoplasms; Head and Neck Neoplasms; Humans; Laser Coagulation; Light Coagulation; Low-Level Light Therapy; Pentoxifylline; Photochemotherapy; Radiation Injuries; Ranibizumab; Retina; Retinal Diseases; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2011 |
1 other study(ies) available for almagate and Injuries, Radiation
Article | Year |
---|---|
Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.
Topics: Aptamers, Nucleotide; Brachytherapy; Choroid Neoplasms; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Injections; Melanoma; Middle Aged; Optic Disk; Radiation Injuries; Retina; Retinal Hemorrhage; Retinal Neovascularization; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |